Proactive Investors

Ilika Hits Key Manufacturing Milestones as Automotive Partnerships Grow - Part 4

Ilika’s latest update highlights a series of manufacturing milestones as it moves solid‑state battery technology toward commercial scale. The company cites deepening ties with high‑profile OEM Jaguar Land Rover, academic input from Oxford’s Professor Paul Shearing, and a strategic partnership with the UK Battery Industrialisation Centre (UK BIC) to accelerate electrode coating and large‑volume production. Central to the rollout is the PRIMED programme, which structures development into A‑sample (minimum viable product), B‑sample (industrial‑scale equipment) and C‑sample (limited production run) stages. Alongside these technical steps, Ilika is building a robust economic model and conducting a business‑case review with HSSMI, aiming to prove commercial viability within the next 12‑24 months. The firm points to concrete proof points on the horizon: performance feedback on 10 Ah prototype cells released at the end of 2025, similar to the earlier 2 Ah cells, and potential licensing agreements mirroring its Stereax success. Executives envision a future where Ilika’s solid‑state batteries power electric vehicles, underscoring the strategic importance of these collaborations. If Ilika achieves its target of two production‑ready product lines—Stereax in medical devices and Goliath solid‑state batteries for EVs—by decade’s end, it could secure a self‑sustaining revenue stream and become a key supplier in the emerging EV battery market.